Health and Healthcare

All Health and Healthcare Articles

Newest first · Page 388

FDA Fast Tracks Stem Cells for Crohn’s Disease

Osiris Therapeutics (OSIR) was notified that its PROCHYMAL received FDA ‘Fast Track’designation, expediting thedevelopment of the stem cell treatment for Crohn’s Disease that fails to respond to standard therapies.   This takes it to Phase…

Douglas A. McIntyre · 20 years ago

Friday’s Top Biotech and Medical Stocks

From Biohealth Investor Biotechnology NEURALSTEM INC +9.09% POLYDEX PHARM LTD +8.77% MEMORY PHARMACEUTICA +7.32% STEMCELLS INC +6.75% KOSAN BIOSCIENCES +5.78% Diagnostic Substances ICAGEN, INC. +22.81% RG GLBL LIFESTYLS +21.53% BIOSITE INC +7.54% GENE LOGIC…

Douglas A. McIntyre · 20 years ago

IBD Weekly Top Ranked Medical Stocks

From BioHealth Investor The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative Strength by Investor’s Business Daily (1/06/06) scores out of 100 (last week’s rank, change…

Douglas A. McIntyre · 20 years ago

The Biotech Industry: 30 Years of Failure

From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotechnology as a business arguably began with the birth of Genentech (DNA) 30 years ago in 1976. The company had a successful IPO four years later in…

Douglas A. McIntyre · 20 years ago

Cramer’s #3 Speculative Stock for 2007

Tonight Cramer continued his quest of delivering his favorite TOP 3 SPECULATIVE STOCKS FOR 2007.  Cramer started off with his #3 pick, or the second runner up for the speculative stocks. Savient Pharma (SVNT)…

Douglas A. McIntyre · 20 years ago

Bioject’s Needle-Free Delivery Technology Used by NIH

From BioHealth Investor Bioject Medical Technologies Inc (BJCT) announced early Thursday that the National Institutues of Health (NIH) has initiated its DNA vaccine study to prevent the H5N1 flu virus using the company’s needl-free…

Douglas A. McIntyre · 20 years ago

Thursday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology INNOVIVE PHARMACEUTL +23.46% XTL BIOPHARMACEUTICA +22.88% STEMCELLS INC +16.92% MEMORY PHARMACEUTICA +16.73% BIONOVO INC +14.55% Diagnostic Substances RG GLBL LIFESTYLS +47.39% ORCHID CELLMARK INC +11.68% IMMUCOR INC +7.40% GENELABS TECH…

Douglas A. McIntyre · 20 years ago

Stem Cell Stocks Jump on New Congress Promise

From BioHealth Investor by H.S. AyoubBioHealth Investor Stem cell stocks gained big time on Thursday as the new U.S. congress was set to take helm. The new Domocratic agenda promises to ease restrictions on…

Douglas A. McIntyre · 20 years ago

The Smart Money Dumps Generic Drugs

Stocks:  (PFE)(MRK)(TEVA) Conventional wisdom has been that generic drug companies are going to put Big Pharma out of business. As major drugs come "off patent", the generic guys snap them up and sell them…

Douglas A. McIntyre · 20 years ago

Will Pfizer Cut Its Own Throat? (PFE)

Pfizer is raising prices on its drugs an average of about 5% going into 2007. Lipitor, the world’s top-selling drug, will see of price increase of at least that much. After the failure its…

Douglas A. McIntyre · 20 years ago

Wednesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology INNCARDIO INC +23.76% CYTOKINETICS +11.50% PIPEX PHARMACEUTICAL +11.30% BIONOVO INC +10.74% MEMORY PHARMACEUTICA +10.25% Diagnostic Substances CYTOGEN CORP +9.44% ICAGEN, INC. +6.93% AVIGEN INC +4.17% EPICEPT CORPORATION +3.50% PONIARD PHARMA…

Douglas A. McIntyre · 20 years ago

Indian Generic Drug Maker Targets Sad Americans

From BioHealth I read a very well written article penned recently by Nature staff reporter Erika Check for Wired Magazine. Ms.Check profiles a popular nationalist in India by the name of Khwaja Abdul Hamied,…

Douglas A. McIntyre · 20 years ago

Vertex Hepititis C Candidate May Be a Success Story

From BioHealth Investor It seems like Vertex Pharmaceuticals (VRTX) is the subject of the majority of my articles (link one, two, three to past articles) and for good reasons. VRTX is looking to become…

Douglas A. McIntyre · 20 years ago